{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:50Z","timestamp":1792782890911,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82205009"],"award-info":[{"award-number":["82205009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Health Commission Clinical Research Project","award":["20214Y0178"],"award-info":[{"award-number":["20214Y0178"]}]},{"name":"Shanghai Shenkang Three-Year Action Plan for Promoting Clinical Skills and Clinical Innovation in Municipal Hospitals-Research Physician Training in Innovative and Translational Capabilities Project","award":["SHDC2022CRD009"],"award-info":[{"award-number":["SHDC2022CRD009"]}]},{"name":"Shanghai Hospital Collaborative Innovation Centre for Industrial Transformation of Chinese Pharmaceutical Preparations project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-024-01539-1","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T08:52:55Z","timestamp":1736931175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Yunyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufa","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"7","key":"1539_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1539_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2478\/jtim-2019-0029","volume":"7","author":"Y Ke","year":"2019","unstructured":"Ke Y, Xu C, Lin J, Li Y. Role of hepatokines in non-alcoholic fatty liver disease. J Transl Int Med. 2019;7(4):143\u20138.","journal-title":"J Transl Int Med"},{"issue":"3","key":"1539_CR3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/nu13031013","volume":"13","author":"JH Oh","year":"2021","unstructured":"Oh JH, Lee JH, Cho MS, et al. Characterization of gut microbiome in Korean patients with metabolic associated fatty liver disease. Nutrients. 2021;13(3):1013.","journal-title":"Nutrients"},{"issue":"4","key":"1539_CR4","first-page":"359","volume":"8","author":"M Duriez","year":"2020","unstructured":"Duriez M, Jacquet A, Hoet L, et al. A 3D human liver model of nonalcoholic steatohepatitis. J Clin Transl Hepatol. 2020;8(4):359\u201370.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"1539_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"11","key":"1539_CR6","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/hep4.2061","volume":"6","author":"C Van Dongen","year":"2022","unstructured":"Van Dongen C, Paik JM, Harring M, et al. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatol Commun. 2022;6(11):3140\u201353.","journal-title":"Hepatol Commun"},{"issue":"3","key":"1539_CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","volume":"8","author":"AJ McCullough","year":"2004","unstructured":"McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):521\u201333.","journal-title":"Clin Liver Dis"},{"key":"1539_CR8","doi-asserted-by":"crossref","first-page":"8284107","DOI":"10.1155\/2018\/8284107","volume":"2018","author":"L Xu","year":"2018","unstructured":"Xu L, Yu Y, Sang R, Li J, Ge B, Zhang X. Protective effects of taraxasterol against ethanol-induced liver injury by regulating CYP2E1\/Nrf2\/HO-1 and NF-\u03baB signaling pathways in mice. Oxid Med Cell Longev. 2018;2018:8284107.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"1539_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3350\/cmh.2024.0047","volume":"30","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Zhao L, Xiong Z, et al. Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;30(3):449\u201367.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"1539_CR10","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-019-09852-0","volume":"10","author":"HH Guo","year":"2019","unstructured":"Guo HH, Feng CL, Zhang WX, et al. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nat Commun. 2019;10(1):1981.","journal-title":"Nat Commun"},{"issue":"9","key":"1539_CR11","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/cancers14092081","volume":"14","author":"BK Bae","year":"2022","unstructured":"Bae BK, Park HC, Yoo GS, Choi MS, Joo Hyun O, Jeong Il Y. The significance of systemic inflammation markers in intrahepatic recurrence of early-stage hepatocellular carcinoma after curative treatment. Cancers. 2022;14(9):2081. https:\/\/doi.org\/10.3390\/cancers14092081.","journal-title":"Cancers"},{"issue":"1","key":"1539_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s42358-020-0113-5","volume":"60","author":"MH Al-Osami","year":"2020","unstructured":"Al-Osami MH, Awadh NI, Khalid KB, Awadh AI. Neutrophil\/lymphocyte and platelet\/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study. Adv Rheumatol. 2020;60(1):13.","journal-title":"Adv Rheumatol"},{"key":"1539_CR13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.655000","volume":"11","author":"M Adamkiewicz","year":"2021","unstructured":"Adamkiewicz M, Bryniarski P, Kowalik M, Burzy\u0144ski B, Rajwa P, Paradysz A. Lymphocyte-to-monocyte ratio is the independent prognostic marker of progression in patients undergoing BCG-immunotherapy for bladder cancer. Front Oncol. 2021;11: 655000.","journal-title":"Front Oncol"},{"issue":"11","key":"1539_CR14","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1634\/theoncologist.2018-0789","volume":"24","author":"X Feng","year":"2019","unstructured":"Feng X, Li L, Wu J, et al. Complete blood count score model integrating reduced lymphocyte-monocyte ratio, elevated neutrophil-lymphocyte ratio, and elevated platelet-lymphocyte ratio predicts inferior clinical outcomes in adult T-lymphoblastic lymphoma. Oncologist. 2019;24(11):e1123\u201331.","journal-title":"Oncologist"},{"issue":"1","key":"1539_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12885-020-6698-6","volume":"20","author":"LJ Xia","year":"2020","unstructured":"Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1\u20132 rectal cancer. BMC Cancer. 2020;20(1):208.","journal-title":"BMC Cancer"},{"issue":"1","key":"1539_CR16","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1038\/s41598-024-72027-5","volume":"14","author":"Y He","year":"2024","unstructured":"He Y, Liu X, Wang M, Ke H, Ge C. Neutrophil-to-lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors. Sci Rep. 2024;14(1):20980.","journal-title":"Sci Rep"},{"issue":"8","key":"1539_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.31083\/j.rcm2508294","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Guo J, Chen M, Wang Y, Li J, Zhang J. Pan-immune-inflammatory value is superior to other inflammatory indicators in predicting inpatient major adverse cardiovascular events and severe coronary artery stenosis after percutaneous coronary intervention in STEMI patients. Rev Cardiovasc Med. 2024;25(8):294.","journal-title":"Rev Cardiovasc Med"},{"key":"1539_CR18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102636","volume":"92","author":"C Jiang","year":"2024","unstructured":"Jiang C, Wu Y, Huang J, Wang Y, Cong H. Clinical value of complete blood count ratio in benign and malignant thyroid diseases. Cancer Epidemiol. 2024;92: 102636.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"1539_CR19","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"issue":"1","key":"1539_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","volume":"34","author":"YH Oo","year":"2010","unstructured":"Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun. 2010;34(1):45\u201354.","journal-title":"J Autoimmun"},{"key":"1539_CR21","doi-asserted-by":"crossref","first-page":"1337241","DOI":"10.3389\/fimmu.2024.1337241","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, Tang S, Liu C, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241.","journal-title":"Front Immunol"},{"key":"1539_CR22","doi-asserted-by":"crossref","first-page":"1389967","DOI":"10.3389\/fimmu.2024.1389967","volume":"15","author":"H Gong","year":"2024","unstructured":"Gong H, He Q, Zhu L, et al. Associations between systemic inflammation indicators and nonalcoholic fatty liver disease: evidence from a prospective study. Front Immunol. 2024;15:1389967.","journal-title":"Front Immunol"},{"issue":"2","key":"1539_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MEG.0000000000002686","volume":"36","author":"G Wang","year":"2024","unstructured":"Wang G, Zhao Y, Li Z, et al. Association between novel inflammatory markers and non-alcoholic fatty liver disease: a cross-sectional study. Eur J Gastroenterol Hepatol. 2024;36(2):203\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1539_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5152\/tjg.2022.20715","volume":"33","author":"J WenYi","year":"2022","unstructured":"WenYi J, Ting Q, PiaoPiao Y, JinMing W. Association between neutrophil-to-lymphocyte ratio with inflammatory activity and fibrosis in non-alcoholic fatty liver disease. Turk J Gastroenterol. 2022;33(1):53\u201361.","journal-title":"Turk J Gastroenterol"},{"issue":"11","key":"1539_CR25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/MEG.0000000000002439","volume":"34","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Tian N, Li P, He Y, Tong L, Xie W. The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study. Eur J Gastroenterol Hepatol. 2022;34(11):1158\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"1539_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cgh.2015.08.010","volume":"14","author":"F Kanwal","year":"2016","unstructured":"Kanwal F, Kramer JR, Duan Z, Yu X, White D, El-Serag HB. Trends in the burden of nonalcoholic fatty liver disease in a united states cohort of veterans. Clin Gastroenterol Hepatol. 2016;14(2):301\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1539_CR27","doi-asserted-by":"crossref","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65-W\u221294.","journal-title":"Ann Intern Med"},{"key":"1539_CR28","unstructured":"Wells GA, Wells G, Shea B, et al. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014."},{"key":"1539_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1539_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/1469-0691.12494","volume":"20","author":"WG Melsen","year":"2014","unstructured":"Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20(2):123\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1539_CR31","first-page":"278","volume":"45","author":"H Yilmaz","year":"2015","unstructured":"Yilmaz H, Yalcin KS, Namuslu M, et al. Neutrophil-lymphocyte ratio (NLR) could be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis(NASH). Ann Clin Lab Sci. 2015;45(3):278\u201386.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"1539_CR32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MEG.0000000000000486","volume":"28","author":"A Abdel-Razik","year":"2016","unstructured":"Abdel-Razik A, Mousa N, Shabana W, et al. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Eur J Gastroenterol Hepatol. 2016;28(1):e1-9.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"1539_CR33","first-page":"295","volume":"79","author":"NK Kahraman","year":"2016","unstructured":"Kahraman NK, Kahraman C, Ko\u00e7ak FE, et al. Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients. Acta Gastroenterol Belg. 2016;79(3):295\u2013300.","journal-title":"Acta Gastroenterol Belg"},{"issue":"12","key":"1539_CR34","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.22627","volume":"27","author":"J Chen","year":"2019","unstructured":"Chen J, Zheng M, Liu J, et al. Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis. Obesity (Silver Spring). 2019;27(12):2055\u201366.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"1539_CR35","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.dsx.2019.05.032","volume":"13","author":"AS Hanafy","year":"2019","unstructured":"Hanafy AS, Seleem WM, El-Kalla F, AbdAlkhalik Basha M, Abd-Elsalam S. Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease. Diabetes Metab Syndr. 2019;13(3):2272\u20138.","journal-title":"Diabetes Metab Syndr"},{"issue":"47","key":"1539_CR36","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.3748\/wjg.v26.i47.7538","volume":"26","author":"A Michalak","year":"2020","unstructured":"Michalak A, Cicho\u017c-Lach H, Guz M, et al. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. World J Gastroenterol. 2020;26(47):7538\u201349.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"1539_CR37","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/MEG.0000000000001845","volume":"33","author":"E Pur\u00f3n-Gonz\u00e1lez","year":"2021","unstructured":"Pur\u00f3n-Gonz\u00e1lez E, Gonz\u00e1lez-Cant\u00fa A, Coronado-Alejandro EU, S\u00e1nchez-D\u00e1vila OE, Cobos-Aguilar H, Romero-Ibarguengoitia ME. Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. Eur J Gastroenterol Hepatol. 2021;33(10):1316\u201321.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"17\u201318","key":"1539_CR38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00508-022-02029-8","volume":"134","author":"M Kohsari","year":"2022","unstructured":"Kohsari M, Moradinazar M, Rahimi Z, Najafi F, Pasdar Y, Shakiba E. New inflammatory biomarkers (lymphocyte and monocyte percentage to high-density lipoprotein cholesterol ratio and lymphocyte to monocyte percentage ratio) and their association with some cardiometabolic diseases: results from a large Kurdish cohort study in Iran. Wien Klin Wochenschr. 2022;134(17\u201318):626\u201335.","journal-title":"Wien Klin Wochenschr"},{"issue":"17","key":"1539_CR39","first-page":"2126","volume":"25","author":"J Ma","year":"2022","unstructured":"Ma J, Zhang X. Predictive value of monocyte-to-high-density lipoprotein cholesterol ratio for non-alcoholic fatty liver disease combined with metabolic syndrome in community-dwelling patients and multifactorial logistic decision tree analysis. Chin Fam Med. 2022;25(17):2126\u201334.","journal-title":"Chin Fam Med"},{"key":"1539_CR40","doi-asserted-by":"crossref","first-page":"981196","DOI":"10.3389\/fendo.2022.981196","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Xia J, He H, Liang S, Zhang H, Gan W. Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease. Front Endocrinol Lausanne. 2022;13:981196.","journal-title":"Front Endocrinol Lausanne"},{"issue":"1","key":"1539_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12890-022-02291-6","volume":"22","author":"M Chen","year":"2022","unstructured":"Chen M, Wang B, Huang J, Zhao J, Chen J, Chen G. The role of platelet-related parameters for the prediction of NAFLD in OSAHS patients. BMC Pulm Med. 2022;22(1):487.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"1539_CR42","volume":"15","author":"DC Cucoranu","year":"2023","unstructured":"Cucoranu DC, Pop M, Niculescu R, et al. The association of nonalcoholic fatty liver disease with neutrophil-to-lymphocyte ratio and neutrophil-percentage-to-albumin ratio. Cureus. 2023;15(6): e41197.","journal-title":"Cureus"},{"key":"1539_CR43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/NDT.S398385","volume":"19","author":"X Li","year":"2023","unstructured":"Li X, Gao Y, Wang Y, Wang Y, Wu Q. Prevalence and influence factors for non-alcoholic fatty liver disease in long-term hospitalized patients with schizophrenia: a cross-sectional retrospective study. Neuropsychiatr Dis Treat. 2023;19:379\u201389.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"1539_CR44","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/nu15081892","volume":"15","author":"C-F Liu","year":"2023","unstructured":"Liu C-F, Chien L-W. Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017\u20132018. Nutrients. 2023;15(8):1892. https:\/\/doi.org\/10.3390\/nu15081892.","journal-title":"Nutrients"},{"issue":"1","key":"1539_CR45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","volume":"22","author":"Q Liu","year":"2023","unstructured":"Liu Q, Han M, Li M, et al. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids Health Dis. 2023;22(1):185.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1539_CR46","volume":"10","author":"G Chen","year":"2024","unstructured":"Chen G, Fan L, Yang T, et al. Prognostic nutritional index (PNI) and risk of non-alcoholic fatty liver disease and advanced liver fibrosis in US adults: Evidence from NHANES 2017\u20132020. Heliyon. 2024;10(4): e25660.","journal-title":"Heliyon"},{"issue":"1","key":"1539_CR47","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/s41598-024-56796-7","volume":"14","author":"EK Choe","year":"2024","unstructured":"Choe EK, Kang HY. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population. Sci Rep. 2024;14(1):6118.","journal-title":"Sci Rep"},{"issue":"5","key":"1539_CR48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese M, Cabrera D, Kalergis AM, Feldstein AE. Innate Immunity and Inflammation in NAFLD\/NASH. Dig Dis Sci. 2016;61(5):1294\u2013303.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1539_CR49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"1539_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"1539_CR51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12876-015-0378-z","volume":"15","author":"JH Kwon","year":"2015","unstructured":"Kwon JH, Jang JW, Kim YW, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol. 2015;15:146.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"1539_CR52","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/apt.14046","volume":"45","author":"YJ Cai","year":"2017","unstructured":"Cai YJ, Dong JJ, Dong JZ, et al. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45(11):1413\u201326.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1539_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/lt.24702","volume":"23","author":"A Kalra","year":"2017","unstructured":"Kalra A, Wedd JP, Bambha KM, et al. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis. Liver Transpl. 2017;23(2):155\u201365.","journal-title":"Liver Transpl"},{"key":"1539_CR54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cca.2017.04.011","volume":"469","author":"YJ Cai","year":"2017","unstructured":"Cai YJ, Dong JJ, Dong JZ, et al. Neutrophil-lymphocyte ratio predicts hospital-acquired bacterial infections in decompensated cirrhosis. Clin Chim Acta. 2017;469:201\u20137.","journal-title":"Clin Chim Acta"},{"key":"1539_CR55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/DMSO.S330526","volume":"15","author":"CRA Lesmana","year":"2022","unstructured":"Lesmana CRA, Kencana Y, Rinaldi I, et al. Diagnostic value of neutrophil to lymphocyte ratio in non-alcoholic fatty liver disease evaluated using transient elastography (TE) with controlled attenuated parameter (CAP). Diabetes Metab Syndr Obes. 2022;15:15\u201322.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"1539_CR56","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"2","key":"1539_CR57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1478-3231.2011.02639.x","volume":"32","author":"N Alkhouri","year":"2012","unstructured":"Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):297\u2013302.","journal-title":"Liver Int"},{"issue":"11","key":"1539_CR58","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(11):3863. https:\/\/doi.org\/10.3390\/ijms21113863.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1539_CR59","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1080\/22221751.2022.2077128","volume":"11","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang Y, Zhou P, et al. Down-regulated cylindromatosis enhances NF-\u03baB activation and aggravates inflammation in HBV-ACLF patients. Emerg Microbes Infect. 2022;11(1):1586\u2013601.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"1539_CR60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3748\/wjg.v19.i1.57","volume":"19","author":"S Zelber-Sagi","year":"2013","unstructured":"Zelber-Sagi S, Webb M, Assy N, et al. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol. 2013;19(1):57\u201364.","journal-title":"World J Gastroenterol"},{"key":"1539_CR61","unstructured":"Greer JP, Arber DA, Glader B et al. Wintrobe\u2019s clinical hemnatology. Asia Book Registry. 2019."},{"issue":"6","key":"1539_CR62","volume":"4","author":"I Graupera","year":"2022","unstructured":"Graupera I, Isus L, Coll M, et al. Molecular characterization of chronic liver disease dynamics: from liver fibrosis to acute-on-chronic liver failure. JHEP Rep. 2022;4(6): 100482.","journal-title":"JHEP Rep"},{"issue":"1","key":"1539_CR63","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1038\/s41598-018-28563-y","volume":"8","author":"T Taipale","year":"2018","unstructured":"Taipale T, Sepp\u00e4l\u00e4 I, Raitoharju E, et al. Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study. Sci Rep. 2018;8(1):10358.","journal-title":"Sci Rep"},{"key":"1539_CR64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842636","volume":"13","author":"A Dalbeni","year":"2022","unstructured":"Dalbeni A, Castelli M, Zoncap\u00e8 M, Minuz P, Sacerdoti D. Platelets in non-alcoholic fatty liver disease. Front Pharmacol. 2022;13: 842636.","journal-title":"Front Pharmacol"},{"key":"1539_CR65","volume":"10","author":"Y Duan","year":"2022","unstructured":"Duan Y, Luo J, Pan X, et al. Association between inflammatory markers and non-alcoholic fatty liver disease in obese children. Front Public Health. 2022;10: 991393.","journal-title":"Front Public Health"},{"issue":"3","key":"1539_CR66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eprac.2021.11.083","volume":"28","author":"P Hashemi Moghanjoughi","year":"2022","unstructured":"Hashemi Moghanjoughi P, Neshat S, Rezaei A, Heshmat-Ghahdarijani K. Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes? Endocr Pract. 2022;28(3):342\u20138.","journal-title":"Endocr Pract"},{"issue":"1","key":"1539_CR67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12902-024-01564-x","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu H. Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients. BMC Endocr Disord. 2024;24(1):42.","journal-title":"BMC Endocr Disord"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01539-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:53:42Z","timestamp":1764917622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01539-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was not required as this was a systematic review of published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"39"}}